These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3986127)

  • 21. Fenofibrate inhibits reactive amyloidosis in mice.
    Murai T; Yamada T; Miida T; Arai K; Endo N; Hanyu T
    Arthritis Rheum; 2002 Jun; 46(6):1683-8. PubMed ID: 12115201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ascorbic acid 2-glucocide reduces micronucleus induction in distant splenic T lymphocytes following head irradiation.
    Kinashi Y; Tanaka H; Masunaga S; Suzuki M; Kashino G; Yong L; Takahashi S; Ono K
    Mutat Res; 2010 Jan; 695(1-2):69-74. PubMed ID: 20006734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine alveolar hydatidosis: a potential experimental model for the study of AA-amyloidosis.
    Ali-Khan Z; Jothy S; Al-Karmi T
    Br J Exp Pathol; 1983 Dec; 64(6):599-611. PubMed ID: 6661394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine amyloid protein AA in casein-induced experimental amyloidosis.
    Skinner M; Shirahama T; Benson MD; Cohen AS
    Lab Invest; 1977 Apr; 36(4):420-7. PubMed ID: 403374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
    Grehan S; Herbert J; Whitehead AS
    Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents.
    Shtrasburg S; Pras M; Rabinovich E; Gal R; Livneh A; Lidar M
    Autoimmun Rev; 2012 Nov; 12(1):18-21. PubMed ID: 22878271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A noninvasive screening of systemic reactive (secondary) AA amyloidosis, based on reduced amyloid degrading activity of amyloidotic serum.
    Ravid M; Greenman Y; Shapira J; Kedar I
    Isr J Med Sci; 1990 Apr; 26(4):191-4. PubMed ID: 2347684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusible amyloid oligomers trigger systemic amyloidosis in mice.
    Senthilkumar S; Chang E; Jayakumar R
    Biochem J; 2008 Oct; 415(2):207-15. PubMed ID: 18564059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
    Lyon AW; Anastassiades T; Kisilevsky R
    J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Casein-induced experimental amyloidosis. V. The response of lymphoid organs to T and B mitogens.
    Scheinberg MA; Bennett M; Cathcart ES
    Lab Invest; 1975 Jul; 33(1):96-101. PubMed ID: 49456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceleration of murine amyloidosis by implantation of amyloid-containing grafts.
    Ono S; Cui D; Kunitsugu I; Hoshii Y; Kawano H; Takahashi M; Gondo T; Ishihara T
    Amyloid; 2005 Dec; 12(4):226-32. PubMed ID: 16399647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine inhibition of casein-induced amyloidosis in mice.
    Kedar I; Ravid M; Sohar E; Gafni J
    Isr J Med Sci; 1974 Jul; 10(7):787-9. PubMed ID: 4851072
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR; Cathcart ES
    Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal amyloidosis in KK mice that may be misinterpreted as diabetic glomerulosclerosis.
    Soret MG; Peterson T; Wyse B; Block EM; Dulin WE
    Arch Pathol Lab Med; 1977 Sep; 101(9):464-8. PubMed ID: 578106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of amyloidosis using low-molecular-weight heparins.
    Zhu H; Yu J; Kindy MS
    Mol Med; 2001 Aug; 7(8):517-22. PubMed ID: 11591887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
    Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
    J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo antineoplastic activity of ascorbic acid for human mammary tumor.
    Tsao CS; Dunham WB; Leung PY
    In Vivo; 1988; 2(2):147-50. PubMed ID: 2979831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.